#clinicaldata — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #clinicaldata, aggregated by home.social.
-
AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure
AstraZeneca reported positive results from two non-small cell lung cancer trials for Enhertu and an Orpathys-Tagrisso combination, although…
#EuropeSays #Britain #Europe #EU #AstraZeneca #antibody-drugconjugates #clinicaldata #DaiichiSankyo #EGFR-mutatedlungcancer #Enhertu #FiercePharmaHomepage #HER2 #Hutchmed #METinhibitor #non-smallcelllungcancer #Pharma #savolitinib #Tagrisso
https://www.europesays.com/britain/105261/ -
https://www.europesays.com/britain/105261/ AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure #AntibodyDrugConjugates #AstraZeneca #ClinicalData #DaiichiSankyo #EGFRMutatedLungCancer #Enhertu #FiercePharmaHomepage #HER2 #Hutchmed #METInhibitor #NonSmallCellLungCancer #Pharma #savolitinib #Tagrisso
-
GSK to seek FDA approval for Jemperli in high-profile cancer use
In what GSK says represents a potential way to transform treatment for patients with certain types of rectal…
#EuropeSays #Britain #Europe #EU #GSK #clinicaldata #colorectalcancer #FDA #FiercePharmaHomepage #Jemperli #PD-1 #Pharma
https://www.europesays.com/britain/104655/ -
https://www.europesays.com/britain/104655/ GSK to seek FDA approval for Jemperli in high-profile cancer use #ClinicalData #ColorectalCancer #FDA #FiercePharmaHomepage #GSK #Jemperli #PD1 #Pharma
-
https://www.europesays.com/uk/1149251/ EU regulators offer post-mortem of Tavneos withdrawal decision #Amgen #AutoimmuneDiseases #ChemoCentryx #CHMPRecommendation #ClinicalData #CSL #DrugSafety #EU #Europe #European #EuropeanCommission #EuropeanMedicinesAgency #EuropeanUnion #FiercePharmaHomepage #pharma #RareDiseases #Tavneos
-
Tavneos trial flagged for ‘serious breaches’ of protocol as EU regulators dissect market withdrawal decision
With the European Union formally reversing its marketing authorization for rare disease med Tavneos last week, regulators from…
#Europe #EU #Amgen #Autoimmunediseases #ChemoCentryx #CHMPrecommendation #clinicaldata #CSL #drugsafety #EuropeanCommission #EuropeanMedicinesAgency #EuropeanUnion #FiercePharmaHomepage #Pharma #rarediseases #TAVNEOS
https://www.europesays.com/europe/116043/ -
https://www.europesays.com/ch/115157/ Roche heads to regulators with new autoimmune win for Gazyva #AutoimmuneDiseases #ClinicalData #EuropeanMedicinesAgency #FDA #FiercePharmaHomepage #Gazyva #kidneys #nephropathy #obinutuzumab #Pharma #Roche #USFDA
-
https://www.europesays.com/dk/138372/ ZEUS failure clouds future of Novo’s cardiovascular plans #ClinicalData #NovoNordisk
-
ZEUS failure clouds future of Novo’s cardiovascular plans
Why it matters: The setback weakens Novo’s attempt to build a cardiovascular business beyond its obesity and diabetes…
#Europe #EU #clinicaldata #European
https://www.europesays.com/europe/106860/ -
GSK partner Hansoh reports another phase 3 win for priority ADC
Hansoh Pharmaceutical has guided its GSK-partnered, B7-H3-directed antibody-drug conjugate (ADC) to another phase 3 win in China. Weeks after reporting…
#EuropeSays #Britain #Europe #EU #GSK #antibody-drugconjugates #biotech #clinicaldata #FierceBiotechHomepage #HansohPharma #osteosarcoma
https://www.europesays.com/britain/94082/ -
https://www.europesays.com/britain/94082/ GSK partner Hansoh reports another phase 3 win for priority ADC #AntibodyDrugConjugates #biotech #ClinicalData #FierceBiotechHomepage #GSK #HansohPharma #osteosarcoma
-
Sanofi axes two more inflammatory-disease drugs
Why it matters: The decisions remove two externally sourced drugs from Sanofi’s immunology pipeline, days after the French…
#France #FR #Europe #EU #Sanofi #ClinicalData
https://www.europesays.com/france/59281/ -
AstraZeneca updates Ultomiris HSCT-TMA Phase III data | AZN SEC Filing
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant…
#EuropeSays #Britain #Europe #EU #AstraZeneca #AZN #BreakthroughTherapy #clinicaldata #HSCT-TMA #OrphanDrug #paediatricsurvival #PhaseIIItrial #SECfiling #Ultomiris
https://www.europesays.com/britain/91592/ -
https://www.europesays.com/britain/91592/ AstraZeneca updates Ultomiris HSCT-TMA Phase III data | AZN SEC Filing #AstraZeneca #AZN #BreakthroughTherapy #ClinicalData #HSCTTMA #OrphanDrug #PaediatricSurvival #PhaseIIITrial #SECFiling #Ultomiris
-
Sanofi drops eczema drug from $1.1B Kymab deal
Why it matters: Amlitelimab was the principal asset behind Sanofi’s $1.1 billion acquisition of Cambridge, UK-based Kymab in…
#France #FR #Europe #EU #Sanofi #ClinicalData
https://www.europesays.com/france/56400/ -
https://www.europesays.com/ch/106498/ Novartis drops Phase 2 radioligand therapy #ClinicalData #Novartis
-
GSK setback deepens P2X3 cough drug doubts
Why it matters: P2X3 antagonists were expected to create a new treatment class for patients whose cough persists…
#Europe #EU #clinicaldata #European
https://www.europesays.com/europe/97959/ -
https://www.europesays.com/britain/86400/ GSK setback deepens P2X3 cough drug doubts #ClinicalData #GSK
-
GSK setback deepens P2X3 cough drug doubts
Why it matters: P2X3 antagonists were expected to create a new treatment class for patients whose cough persists…
#EuropeSays #Britain #Europe #EU #GSK #clinicaldata
https://www.europesays.com/britain/86400/ -
Genmab shares rise following positive epcoritamab phase 3 data
Why it matters: Epcoritamab is already approved in later-line lymphoma settings. A positive phase 3 result in patients…
#Europe #EU #clinicaldata #European
https://www.europesays.com/europe/83687/ -
https://www.europesays.com/ch/94532/ Evommune’s phase 2b flops, ending challenge to Novartis in hives #biotech #ChronicSpontaneousUrticaria #ClinicalData #Dermatology #FailedTrials #FierceBiotechHomepage #Novartis
-
ProQR validates RNA editing platform and raises $59.2m
Why it matters: The Leiden-based biotech has spent the past few years repositioning itself around ADAR-mediated RNA editing,…
#Europe #EU #clinicaldata #European
https://www.europesays.com/europe/79780/ -
F2G’s oral antifungal clears Phase III hurdle
Azole antifungals remain the mainstay of treatment for invasive aspergillosis, but they are not suitable for every patient.…
#Europe #EU #clinicaldata #European
https://www.europesays.com/europe/72852/ -
https://www.europesays.com/ch/86592/ As Roche eyes busy 2026, Vabysmo undershoots targets and Tecentriq fails early lung cancer study #BreastCancer #BTKInhibitors #ClinicalData #Earnings #FiercePharmaHomepage #financials #MultipleSclerosis #NonSmallCellLungCancer #PD1/L1 #Pharma #Roche #Tecentriq #TeresaGraham #Vabysmo #WetAMD
-
https://www.europesays.com/ch/86550/ Novartis to seek full IgAN nod for Vanrafia despite ph. 3 miss #AutoimmuneDiseases #ClinicalData #FiercePharmaHomepage #KidneyDisease #Novartis #Pharma
-
Sanofi’s new COVID shot tops Moderna’s mNEXSPIKE in safety trial
Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a head-to-head trial assessing the…
#France #FR #Europe #EU #Sanofi #ClinicalData #Coronavirus #covid-19 #FiercePharmaHomepage #mNEXSPIKE #Moderna #Novavax #pharma
https://www.europesays.com/france/37348/ -
https://www.europesays.com/ch/86454/ Roche’s Enspryng cuts MOGAD relapse risk by 68% in phase 3 #AmericanAcademyOfNeurology #AutoimmuneDiseases #ClinicalData #ENSPRYNG #FiercePharmaHomepage #Pharma #RareDiseases #Roche
-
https://www.europesays.com/ch/82661/ Roche in part-sale of mixed bag lebrikizumab to Dermira #asthma #biotech #ClinicalData #Deals #Dermatology #Dermira #Esbriet #FierceBiotechHomepage #IdiopathicPulmonaryFibrosis #Intermune #Roche
-
https://www.europesays.com/ch/82235/ Novartis dystrophy data tee up regulatory talks on Avidity drug #biotech #ClinicalData #FierceBiotechHomepage #MuscularDystrophy #Novartis #RareDiseases #siRNA
-
https://www.europesays.com/ch/81977/ Roche’s COPD drug flunks phase 3, denting hopes of 2025 approval #biotech #ChronicObstructivePulmonaryDisease(COPD) #ClinicalData #FailedTrials #FierceBiotechHomepage #MonoclonalAntibodies #Roche
-
I am currently giving a #Programming course in the wider scope of a #MedicalTech / #ClinicalData management training.
Is there anyone in my network who has worked in those areas and can shed some light on how programming plays a role / can be applied in their work?
I am looking for any kind of input on how to tie the somewhat discrete skill of programming with the interdisciplinary field of medical technology and clinical data managment.
Thanks in advance! Boost for reach is appreciated 😘
-
R/Medicine Hackathon is tomorrow!
We will focus specifically on the {teal} package, from the Pharmaverse ecosystem, a framework for building interactive exploratory data analysis applications in clinical trials.
Beginners very welcome, registration for R/Medicine required.
Sign up, prep, and all the deets here: https://rconsortium.github.io/RMedicine_website/Hackathon.html
-
R/Medicine Hackathon is tomorrow!
We will focus specifically on the {teal} package, from the Pharmaverse ecosystem, a framework for building interactive exploratory data analysis applications in clinical trials.
Beginners very welcome, registration for R/Medicine required.
Sign up, prep, and all the deets here: https://rconsortium.github.io/RMedicine_website/Hackathon.html
-
R/Medicine Hackathon is tomorrow!
We will focus specifically on the {teal} package, from the Pharmaverse ecosystem, a framework for building interactive exploratory data analysis applications in clinical trials.
Beginners very welcome, registration for R/Medicine required.
Sign up, prep, and all the deets here: https://rconsortium.github.io/RMedicine_website/Hackathon.html
-
R/Medicine Hackathon is tomorrow!
We will focus specifically on the {teal} package, from the Pharmaverse ecosystem, a framework for building interactive exploratory data analysis applications in clinical trials.
Beginners very welcome, registration for R/Medicine required.
Sign up, prep, and all the deets here: https://rconsortium.github.io/RMedicine_website/Hackathon.html
-
R/Medicine CFP is open 🩺🧪
Deadline: March 6 (still time!)
Submit: Talks • Lightning Talks • Demos • Workshops — share how you use R + Shiny for health, lab, and clinical data.
First-time speaker? Not sure about your abstract? Email for feedback: [email protected]
-
R/Medicine CFP is open 🩺🧪
Deadline: March 6 (still time!)
Submit: Talks • Lightning Talks • Demos • Workshops — share how you use R + Shiny for health, lab, and clinical data.
First-time speaker? Not sure about your abstract? Email for feedback: [email protected]
-
R/Medicine CFP is open 🩺🧪
Deadline: March 6 (still time!)
Submit: Talks • Lightning Talks • Demos • Workshops — share how you use R + Shiny for health, lab, and clinical data.
First-time speaker? Not sure about your abstract? Email for feedback: [email protected]
-
R/Medicine CFP is open 🩺🧪
Deadline: March 6 (still time!)
Submit: Talks • Lightning Talks • Demos • Workshops — share how you use R + Shiny for health, lab, and clinical data.
First-time speaker? Not sure about your abstract? Email for feedback: [email protected]
-
Abbott AFib devices show up to 84% success
Positive 12-month results from the VOLT-AF IDE Study presented at the AF Symposium and simultaneously published in JACC: Clinical Electrophysiology, reinforce…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #BreakingNews #Abbott #ABT #AtrialFibrillation #clinicaldata #Electrophysiology #Headlines #Medicaldevices #TactiFlexDuoAblationCatheter #Topstories #TopStories #VoltPulsedFieldAblationSystem
https://www.newsbeep.com/us/452654/ -
Opus Genetics to Present at Upcoming Medical and Industry Conferences in October 2025
Opus Genetics, Inc. RESEARCH TRIANGLE PARK, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD),…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Genetics #clinicaldata #genetherapies #GeorgeMagrath #IRD #Lebercongenitalamaurosis #PresentationContent #retinaldiseases #Science #visualdisturbances
https://www.newsbeep.com/us/197194/ -
Satellos to Present DMD Drug SAT-3247 Phase 1b Data at WMS 2025
09/29/2025…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #BreakingNews #biotechnology #clinicaldata #DMD #duchennemusculardystrophy #FrankGleeson #Headlines #MSCLF #musclerepair #Phase1bclinicaltrial #SAT-3247 #Satellos #Topstories #TopStories #WildonFarwell #WMS2025 #WorldMuscleSocietyCongress
https://www.newsbeep.com/us/189681/ -
🧬 Can smarter data systems revolutionize how we study gut health in young children?
🔗 Development of a new data management system for the study of the gut microbiome of children who are small for their gestational age. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2024.12.031
📚 CSBJ: https://www.csbj.org/
#GutMicrobiome #ChildHealth #BiomedicalInformatics #MicrobiomeResearch #ClinicalData #DigitalHealth #Pediatrics #GutHealth #ChildDevelopment #BiomedicalInnovation
-
We are pleased to invite you to the upcoming MILA Seminar, featuring Dr. Martin Preusse, CEO and founder of Kaiser & Preusse. Dr. Preusse is a leading expert in knowledge graph applications and health data harmonization solutions for the pharmaceutical and life sciences sectors.
https://unimedizin-greifswald.de/medizininformatik/news/singleview/?tx_ttnews[tt_news]=57
#greifswald #science #healthData #clinicalData #graphDatabase #dataIntegration #seminar
-
We are pleased to invite you to the upcoming MILA Seminar, featuring Dr. Martin Preusse, CEO and founder of Kaiser & Preusse. Dr. Preusse is a leading expert in knowledge graph applications and health data harmonization solutions for the pharmaceutical and life sciences sectors.
https://www.medizin.uni-greifswald.de/medizininformatik/news/singleview/?tx_ttnews[tt_news]=57
#greifswald #science #healthData #clinicalData #graphDatabase #dataIntegration #seminar
-
We are pleased to invite you to the upcoming MILA Seminar, featuring Dr. Martin Preusse, CEO and founder of Kaiser & Preusse. Dr. Preusse is a leading expert in knowledge graph applications and health data harmonization solutions for the pharmaceutical and life sciences sectors.
https://www.medizin.uni-greifswald.de/medizininformatik/news/singleview/?tx_ttnews[tt_news]=57
#greifswald #science #healthData #clinicalData #graphDatabase #dataIntegration #seminar
-
Last week I had the pleasure of attending the 4th Clinic Meets Data Science Symposium in Zürich and to give a talk in which I tried to draw some lessons from my recent efforts in applying deep learning to health data.
The talk was called "All that glitters is not gold: tales from applying deep learning to clinical data" because I was in the mood to be provocative and the slides (pdf) are here: https://cazencott.info/dotclear/public/publications/2024-09-10_azencott.pdf
-
Last week I had the pleasure of attending the 4th Clinic Meets Data Science Symposium in Zürich and to give a talk in which I tried to draw some lessons from my recent efforts in applying deep learning to health data.
The talk was called "All that glitters is not gold: tales from applying deep learning to clinical data" because I was in the mood to be provocative and the slides (pdf) are here: https://cazencott.info/dotclear/public/publications/2024-09-10_azencott.pdf
-
Last week I had the pleasure of attending the 4th Clinic Meets Data Science Symposium in Zürich and to give a talk in which I tried to draw some lessons from my recent efforts in applying deep learning to health data.
The talk was called "All that glitters is not gold: tales from applying deep learning to clinical data" because I was in the mood to be provocative and the slides (pdf) are here: https://cazencott.info/dotclear/public/publications/2024-09-10_azencott.pdf
-
Last week I had the pleasure of attending the 4th Clinic Meets Data Science Symposium in Zürich and to give a talk in which I tried to draw some lessons from my recent efforts in applying deep learning to health data.
The talk was called "All that glitters is not gold: tales from applying deep learning to clinical data" because I was in the mood to be provocative and the slides (pdf) are here: https://cazencott.info/dotclear/public/publications/2024-09-10_azencott.pdf
-
Top FDA official overrules staff to approve gene therapy that failed trial - Enlarge / Dr. Peter Marks, Director of the Center for Biologics Evaluat... - https://arstechnica.com/?p=2032919 #duchennemusculardystrophy #clinicaltrials #clinicaldata #fdaapproval #genetherapy #petermarks #elevidys #science #sarepta #fda
-
Top FDA official overrules staff to approve gene therapy that failed trial - Enlarge / Dr. Peter Marks, Director of the Center for Biologics Evaluat... - https://arstechnica.com/?p=2032919 #duchennemusculardystrophy #clinicaltrials #clinicaldata #fdaapproval #genetherapy #petermarks #elevidys #science #sarepta #fda
-
Top FDA official overrules staff to approve gene therapy that failed trial - Enlarge / Dr. Peter Marks, Director of the Center for Biologics Evaluat... - https://arstechnica.com/?p=2032919 #duchennemusculardystrophy #clinicaltrials #clinicaldata #fdaapproval #genetherapy #petermarks #elevidys #science #sarepta #fda
-
Top FDA official overrules staff to approve gene therapy that failed trial - Enlarge / Dr. Peter Marks, Director of the Center for Biologics Evaluat... - https://arstechnica.com/?p=2032919 #duchennemusculardystrophy #clinicaltrials #clinicaldata #fdaapproval #genetherapy #petermarks #elevidys #science #sarepta #fda
-
🔎#SIBWebsiteTour - What do we bring to the world of science? On our new website, dive into one of our 3 core activities, “Coordination”: https://www.sib.swiss/services/coordination
Explore how we break down siloes to bring together data & experts and maximize public investments by:
🇨🇭 Federating the Swiss community of bioinformatics
🌍 Connecting Swiss bioinformatics to the world
🔬 Implementing impactful research infrastructure initiatives
#bioinformatics #researchinfrastructure #openresearchdata #clinicaldata -
🔎#SIBWebsiteTour - What do we bring to the world of science? On our new website, dive into one of our 3 core activities, “Coordination”: https://www.sib.swiss/services/coordination
Explore how we break down siloes to bring together data & experts and maximize public investments by:
🇨🇭 Federating the Swiss community of bioinformatics
🌍 Connecting Swiss bioinformatics to the world
🔬 Implementing impactful research infrastructure initiatives
#bioinformatics #researchinfrastructure #openresearchdata #clinicaldata -
🔎#SIBWebsiteTour - What do we bring to the world of science? On our new website, dive into one of our 3 core activities, “Coordination”: https://www.sib.swiss/services/coordination
Explore how we break down siloes to bring together data & experts and maximize public investments by:
🇨🇭 Federating the Swiss community of bioinformatics
🌍 Connecting Swiss bioinformatics to the world
🔬 Implementing impactful research infrastructure initiatives
#bioinformatics #researchinfrastructure #openresearchdata #clinicaldata -
🔎#SIBWebsiteTour - What do we bring to the world of science? On our new website, dive into one of our 3 core activities, “Coordination”: https://www.sib.swiss/services/coordination
Explore how we break down siloes to bring together data & experts and maximize public investments by:
🇨🇭 Federating the Swiss community of bioinformatics
🌍 Connecting Swiss bioinformatics to the world
🔬 Implementing impactful research infrastructure initiatives
#bioinformatics #researchinfrastructure #openresearchdata #clinicaldata -
We restart the publication of #clinicaldata for all medicines 💊 as of Sept '23.
‼️Save the date for a webinar we are organising to guide pharma industry, including small & medium-sized enterprises, on the submission of clinical data for publication. https://www.ema.europa.eu/en/events/clinical-data-publication-policy-0070-re-launch-ema-webinar🐦🔗: https://n.respublicae.eu/EMA_News/status/1654018123211718657
-
EMA routinely publishes #ClinicalData supporting the marketing authorisations and #safety monitoring of #COVID19medicines.
We are the 1⃣st regulatory authorities in the world with @GovCanHealth 🇨🇦 to provide such broad online access to clinical data.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1635648718652207106